Methylmalonic acid and homocysteine as indicators of Vitamin B-12 deficiency in cancer

PLoS ONE

Volumn 11, Issue 1, 2016, Pages

  Vashi, Pankaj ^a   Edwin, Persis ^a   Popiel, Brenten ^a   Lammersfeld, Carolyn ^a   Gupta, Digant ^a  

^a Landstuhl Regional Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYANOCOBALAMIN; HOMOCYSTEINE; METHYLMALONIC ACID; BIOLOGICAL MARKER;

ADULT; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; CORRELATION COEFFICIENT; CROSS TABULATION ANALYSIS; CYANOCOBALAMIN DEFICIENCY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ASSOCIATION; DISEASE MARKER; FEDOSOV QUOTIENT; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MIDDLE AGED; OUTCOME ASSESSMENT; PREVALENCE; SPEARMAN RHO CORRELATION COEFFICIENT; STATISTICAL ANALYSIS; AGED; BLOOD; COMPLICATION; CROSS-SECTIONAL STUDY; NEOPLASM; VERY ELDERLY; VITAMIN B 12 DEFICIENCY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; BIOMARKERS; CROSS-SECTIONAL STUDIES; FEMALE; HOMOCYSTEINE; HUMANS; MALE; METHYLMALONIC ACID; MIDDLE AGED; NEOPLASMS; PREVALENCE; VITAMIN B 12 DEFICIENCY; YOUNG ADULT;

EID: 84958191471     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0147843     Document Type: Article

References (30)

1. Oh R, Brown DL. Vitamin B12 deficiency. Am Fam Physician 2003; 67(5):979-986.
2. Schloss JM, Colosimo M, Airey C, Vitetta L. Chemotherapy-induced peripheral neuropathy (CIPN) and vitamin B12 deficiency. Support Care Cancer 2015; 23(7):1843-1850.doi: 10.1007/s00520-015-2725-6
3. Allen LH. How common is vitamin B-12 deficiency? Am J Clin Nutr 2009; 89(2):693S-696S.doi: 10. 3945/ajcn.2008.26947A
4. Schloss JM, Colosimo M, Airey C, Masci PP, Linnane AW, Vitetta L. Nutraceuticals and chemotherapy induced peripheral neuropathy (CIPN): A systematic review. Clin Nutr 2013; 32(6):888-893.doi: 10. 1016/j.clnu.2013.04.007
5. Piccolo J, Kolesar JM. Prevention and treatment of chemotherapy-induced peripheral neuropathy. Am J Health Syst Pharm 2014; 71(1):19-25.doi: 10.2146/ajhp130126
6. Vincenzi B, Frezza AM, Schiavon G, Spoto C, Silvestris N, Addeo R et al. Identification of clinical predictive factors of oxaliplatin-induced chronic peripheral neuropathy in colorectal cancer patients treated with adjuvant Folfox IV. Support Care Cancer 2013; 21(5):1313-1319.doi: 10.1007/s00520-012-1667-5
7. Andres E, Serraj K, Zhu J, Vermorken AJ. The pathophysiology of elevated vitamin B12 in clinical practice. QJM 2013; 106(6):505-515.doi: 10.1093/qjmed/hct051
8. Green R. Indicators for assessing folate and vitamin B-12 status and for monitoring the efficacy of intervention strategies. Am J Clin Nutr 2011; 94(2):666S-672S.doi: 10.3945/ajcn.110.009613
9. Klee GG. Cobalamin and folate evaluation: measurement of methylmalonic acid and homocysteine vs vitamin B(12) and folate. Clin Chem 2000; 46(8 Pt 2):1277-1283.
10. Savage DG, Lindenbaum J, Stabler SP, Allen RH. Sensitivity of serum methylmalonic acid and total homocysteine determinations for diagnosing cobalamin and folate deficiencies. Am J Med 1994; 96 (3):239-246.
11. Solomon LR. Diabetes as a cause of clinically significant functional cobalamin deficiency. Diabetes Care 2011; 34(5):1077-1080.doi: 10.2337/dc11-0009
12. Herrmann W, Obeid R, Schorr H, Geisel J. Functional vitamin B12 deficiency and determination of holotranscobalamin in populations at risk. Clin Chem Lab Med 2003; 41(11):1478-1488.
13. Vugteveen I, Hoeksma M, Monsen AL, Fokkema MR, Reijngoud DJ, van RM et al. Serum vitamin B12 concentrations within reference values do not exclude functional vitamin B12 deficiency in PKU patients of various ages. Mol Genet Metab 2011; 102(1):13-17.doi: 10.1016/j.ymgme.2010.07.004
14. Bailey RL, Carmel R, Green R, Pfeiffer CM, Cogswell ME, Osterloh JD et al. Monitoring of vitamin B-12 nutritional status in the United States by using plasma methylmalonic acid and serum vitamin B-12. Am J Clin Nutr 2011; 94(2):552-561.doi: 10.3945/ajcn.111.015222
15. Palacios G, Sola R, Barrios L, Pietrzik K, Castillo MJ, Gonzalez-Gross M. Algorithm for the early diagnosis of vitamin B12 deficiency in elderly people. Nutr Hosp 2013; 28(5):1447-1452.doi: 10.3305/nh. 2013.28.5.6821
16. Herrmann W, Schorr H, Bodis M, Knapp JP, Muller A, Stein G et al. Role of homocysteine, cystathionine and methylmalonic acid measurement for diagnosis of vitamin deficiency in high-Aged subjects. Eur J Clin Invest 2000; 30(12):1083-1089.
17. Valente E, Scott JM, Ueland PM, Cunningham C, Casey M, Molloy AM. Diagnostic accuracy of holotranscobalamin, methylmalonic acid, serum cobalamin, and other indicators of tissue vitamin B(1)(2) status in the elderly. Clin Chem2011; 57(6):856-863.doi: 10.1373/clinchem.2010.158154
18. Refsum H, Yajnik CS, Gadkari M, Schneede J, Vollset SE, Orning L et al. Hyperhomocysteinemia and elevated methylmalonic acid indicate a high prevalence of cobalamin deficiency in Asian Indians. Am J Clin Nutr 2001; 74(2):233-241.
19. Schneede J, Dagnelie PC, van Staveren WA, Vollset SE, Refsum H, Ueland PM. Methylmalonic acid and homocysteine in plasma as indicators of functional cobalamin deficiency in infants on macrobiotic diets. Pediatr Res 1994; 36(2):194-201.
20. McMullin MF, Young PB, Bailie KE, Savage GA, Lappin TR, White R. Homocysteine and methylmalonic acid as indicators of folate and vitamin B12 deficiency in pregnancy. Clin Lab Haematol 2001; 23 (3):161-165.
21. Schroder TH, Quay TA, Lamers Y. Methylmalonic acid quantified in dried blood spots provides a precise, valid, and stable measure of functional vitamin B-12 status in healthy women. J Nutr 2014; 144 (10):1658-1663.doi: 10.3945/jn.114.194829
22. Obeid R, Jung J, Falk J, HerrmannW, Geisel J, Friesenhahn-Ochs B et al. Serum vitamin B12 not reflecting vitamin B12 status in patients with type 2 diabetes. Biochimie 2013; 95(5):1056-1061.doi: 10.1016/j.biochi.2012.10.028
23. Zweig MH, Campbell G. Receiver-operating characteristic (ROC) plots: A fundamental evaluation tool in clinical medicine. Clin Chem 1993; 39(4):561-577.
24. Greiner M, Pfeiffer D, Smith RD. Principles and practical application of the receiver-operating characteristic analysis for diagnostic tests. Prev Vet Med 2000; 45(1-2):23-41.
25. Fedosov SN, Brito A, Miller JW, Green R, Allen LH. Combined indicator of vitamin B12 status: modification for missing biomarkers and folate status and recommendations for revised cut-points. Clin Chem Lab Med 2015; 53(8):1215-1225.doi: 10.1515/cclm-2014-0818
26. Risch M, Meier DW, Sakem B, Medina EP, Risch C, Nydegger U et al. Vitamin B12 and folate levels in healthy Swiss senior citizens: A prospective study evaluating reference intervals and decision limits. BMC Geriatr 2015; 15:82.doi: 10.1186/s12877-015-0060-x.:82-0060
27. Lee EY, Lee YM, Choi KH, Lee HC, Lee BW, Kim BS. Comparison of two creatinine-based equations for predicting decline in renal function in type 2 diabetic patients with nephropathy in a korean population. Int J Endocrinol 2013; 2013:848963.doi: 10.1155/2013/848963 Epub;%2013 Dec 24.:848963.
28. Selhub J, Jacques PF, Dallal G, Choumenkovitch S, Rogers G. The use of blood concentrations of vitamins and their respective functional indicators to define folate and vitamin B12 status. Food Nutr Bull 2008; 29(2 Suppl):S67-S73.
29. Carmel R. Subclinical cobalamin deficiency. Curr Opin Gastroenterol 2012; 28(2):151-158.doi: 10. 1097/MOG.0b013e3283505852
30. Bolann BJ, Solli JD, Schneede J, Grottum KA, Loraas A, Stokkeland M et al. Evaluation of indicators of cobalamin deficiency defined as cobalamin-induced reduction in increased serum methylmalonic acid. Clin Chem 2000; 46(11):1744-1750